Evidence map›Paper›PMID 40506731›Full record

ReviewMolecular cytogenetics2025

Incorporating automation in a cytogenetics laboratory: three practitioners' perspectives on benefits and limitations.

Cecelia Miller, Jennie Thurston, Ninette Cohen

Abstract readReview
In one paragraph

Review in Molecular cytogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cecelia Miller *Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Jennie Thurston *Cytogenetics and Molecular Pathology, Atrium Health and CPG Pathology, Charlotte, NC, USA.
Ninette Cohen *Department of Pathology and Laboratory Medicine, Division of Cytogenetics and Molecular Pathology, North Shore University Hospital and Long Island Jewish Medical Center, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, Hempstead, NY, USA. ncohen6@northwell.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automation has been developed and continues to be refined for cytogenetics, including advances in the processing of samples, in analysis of conventional chromosome and fluorescence in situ hybridization (FISH) testing, and with artificial intelligence. Here we provide an overview of the various types of automation available to the cytogenetics laboratory and discuss possible benefits and limitations you may encounter based upon our collective experiences.

Indexed as

Artificial intelligence (AI)AutomationChromosome analysisCytogeneticsFluorescence in situ hybridization (FISH)Robotics

Identifiers

PMID40506731
PMCPMC12164055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.